BIOMAT Database Logo BIOMAT Database Logo

Oseltamivir analogs with potent anti-influenza virus activity. 2020

Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Department of Chemistry, Miranda House University Enclave, University of Delhi, Delhi, 110007, India.

Influenza A and B viruses cause seasonal worldwide influenza epidemics each winter, and are a major public health concern and cause of morbidity and mortality. A substantial reduction in influenza-related deaths can be attributed to both vaccination and administration of oseltamivir (OS), which is approved for oral administration and inhibits viral neuraminidase (NA), a transmembrane protein. OS carboxylate (OSC), the active form of OS, is formed by the action of endogenous esterase, which targets NA and is shown to significantly reduce influenza-related deaths. However, the development of resistance in various viral variants, including H3N2 and H5N1, has raised concern about the effectiveness of OS. This comprehensive review covers a range of OS analogs shown to be effective against influenza virus, comparing different types of substituent group that contribute to the activity and bioavailability of these compounds.

UI MeSH Term Description Entries
D008018 Life Cycle Stages The continuous sequence of changes undergone by living organisms during the post-embryonic developmental process, such as metamorphosis in insects and amphibians. This includes the developmental stages of apicomplexans such as the malarial parasite, PLASMODIUM FALCIPARUM. Life Cycle,Life History Stages,Cycle, Life,Cycles, Life,History Stage, Life,History Stages, Life,Life Cycle Stage,Life Cycles,Life History Stage,Stage, Life Cycle,Stage, Life History,Stages, Life Cycle,Stages, Life History
D009439 Neuraminidase An enzyme that catalyzes the hydrolysis of alpha-2,3, alpha-2,6-, and alpha-2,8-glycosidic linkages (at a decreasing rate, respectively) of terminal sialic residues in oligosaccharides, glycoproteins, glycolipids, colominic acid, and synthetic substrate. (From Enzyme Nomenclature, 1992) Sialidase,Exo-alpha-Sialidase,N-Acylneuraminate Glycohydrolases,Oligosaccharide Sialidase,Exo alpha Sialidase,Glycohydrolases, N-Acylneuraminate,N Acylneuraminate Glycohydrolases,Sialidase, Oligosaccharide
D009975 Orthomyxoviridae A family of RNA viruses causing INFLUENZA and other respiratory diseases. Orthomyxoviridae includes INFLUENZAVIRUS A; INFLUENZAVIRUS B; INFLUENZAVIRUS C; INFLUENZAVIRUS D; ISAVIRUS; and THOGOTOVIRUS. Influenza Viruses,Myxoviruses,Orthomyxoviruses,Influenza Virus,Myxovirus,Orthomyxovirus
D009976 Orthomyxoviridae Infections Virus diseases caused by the ORTHOMYXOVIRIDAE. Orthomyxovirus Infections,Infections, Orthomyxoviridae,Infections, Orthomyxovirus,Swine Influenza,Infection, Orthomyxoviridae,Infection, Orthomyxovirus,Influenza, Swine,Orthomyxoviridae Infection,Orthomyxovirus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D053139 Oseltamivir An acetamido cyclohexene that is a structural homolog of SIALIC ACID and inhibits NEURAMINIDASE. GS 4071,GS 4104,GS-4071,GS-4104,GS4071,GS4104,Tamiflu

Related Publications

Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Comparison of anti-influenza virus activity and pharmacokinetics of oseltamivir free base and oseltamivir phosphate.
December 2017, Journal of microbiology (Seoul, Korea),
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Pyrazole compound BPR1P0034 with potent and selective anti-influenza virus activity.
February 2010, Journal of biomedical science,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
A Sulfonozanamivir Analogue Has Potent Anti-influenza Virus Activity.
April 2018, ChemMedChem,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Design of oseltamivir analogs inhibiting neuraminidase of avian influenza virus H5N1.
April 2009, Antiviral research,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Hapivirins and diprovirins: novel θ-defensin analogs with potent activity against influenza A virus.
March 2012, Journal of immunology (Baltimore, Md. : 1950),
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo.
June 2005, Bioorganic & medicinal chemistry,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.
April 2001, Antimicrobial agents and chemotherapy,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Structure-Based Optimization of N-Substituted Oseltamivir Derivatives as Potent Anti-Influenza A Virus Agents with Significantly Improved Potency against Oseltamivir-Resistant N1-H274Y Variant.
November 2018, Journal of medicinal chemistry,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Oseltamivir, an anti-influenza virus drug, produces hypothermia in mice.
April 2008, Biological & pharmaceutical bulletin,
Sumit Kumar, and Steven Goicoechea, and Sonu Kumar, and Catherine M Pearce, and Ravi Durvasula, and Prakasha Kempaiah, and Brijesh Rathi, and Poonam
Inhibitory activity of selenium nanoparticles functionalized with oseltamivir on H1N1 influenza virus.
January 2017, International journal of nanomedicine,
Copied contents to your clipboard!